The heart develops from a linear tubular precursor, which loops to the right and undergoes terminal differentiation to form the multichambered heart. Heart looping is the earliest manifestation of left-right asymmetry and determines the eventual heart situs. The signalling processes that impart laterality to the unlooped heart tube and thus allow the developing organ to interpret the left-right axis of the embryo are poorly understood. Recent experiments in zebrafish led to the suggestion that bone morphogenetic protein 4 (BMP4) may impart laterality to the developing heart tube. Here we show that in Xenopus, as in zebrafish, BMP4 is expressed predominantly on the left of the linear heart tube. Furthermore we demonstrate that ectopic expression of Xenopus nodal-related protein 1 (Xnr1) RNA affects BMP4 expression in the heart, linking asymmetric BMP4 expression to the left-right axis. We show that transgenic embryos overexpressing BMP4 bilaterally in the heart tube tend towards a randomisation of heart situs in an otherwise intact left-right axis. Additionally, inhibition of BMP signalling by expressing noggin or a truncated, dominant negative BMP receptor prevents heart looping but allows the initial events of chamber specification and anteroposterior morphogenesis to occur. Thus in Xenopus asymmetric BMP4 expression links heart development to the left-right axis, by being both controlled by Xnr1 expression and necessary for heart looping morphogenesis.
INTRODUCTION
The heart develops from paired mesodermal precursors that migrate to the ventral midline and fuse to form a tubular intermediate. This tube is initially symmetrical in the left-right axis, but subsequently loops to the right. Dextral looping is the first macroscopic manifestation of left-right asymmetry in the vertebrate embryo. It has thus far been difficult to elucidate the link between the generation of the left-right axis and the control of this looping process.
Recently, much has been learned about the molecular cues that underlie the generation of the left-right axis. It is becoming clear that although the final body plan of vertebrates is generally conserved, the early molecular events generating the left-right axis are not (Capdevila et al., 2000) . The expression of the TGF␤-related molecule nodal along the left lateral plate mesoderm well before manifestation of organogenesis or overt left-right asymmetry is, however, conserved between chick (Levin et al., 1995) , mouse (Collignon et al., 1996; Lowe et al., 1996) , zebrafish (Rebagliati et al., 1998) , and Xenopus (Lohr et al., 1996; Lustig et al., 1996; Lowe et al., 1996) and may thus be a key point in the control of heart situs. Analysis of the mouse situs mutants inv and iv has shown that in both cases, the sidedness of nodal expression correlates with eventual heart situs (Lowe et al., 1996) . Misexpression of Xenopus nodal-related protein 1 (Xnr1) RNA on the right side randomises heart situs (Sampath et al., 1997; Levin et al., 1997) . While Xnr1 expression controls the eventual laterality of the heart tube, it is not expressed in the tube itself (Yokouchi et al., 1999) . Indeed Xnr1 is down-regulated in the left lateral plate mesoderm before the asymmetric looping morphogenesis of the heart (Lustig et al., 1996) . Therefore Xnr1 cannot directly confer "leftness" to the heart. Rather it is more likely that Xnr1 regulates a downstream effector molecule, which does so. The putative signalling link from the left-right axis to the heart should demonstrate two characteristics: (a) side-specific expression in or near the heart anlage which should be affected by perturbations in the left-right axis and (b) misexpression of this signalling molecule should alter the situs of the organ.
The bone morphogenetic proteins (BMP) are a family of signalling molecules implicated in a large number of developmental processes (Hogan, 1996) . BMP4 is a good candidate for a signal controlling the direction of heart looping. Evidence from the chick shows that BMP4 is expressed in the heart tube, and this expression increases around the time of heart looping (Hogan, 1996) . Genetic analysis of heart formation in zebrafish reveals that mutations affecting normal cardiac looping are associated with perturbations in BMP4 expression (normally left sided in the heart tube) in a manner suggesting that lateralised BMP4 expression controls directional heart looping (Chen et al., 1997) . It is plausible to suggest a model whereby BMP4 expression in the heart tube is sensitive to the left-right axis and subsequently imparts this asymmetry to the heart by controlling the direction of cardiac looping. The cellular basis of this process remains to be defined.
Traditional methods of studying the role for BMPs in the control of heart looping have been relatively unsuccessful, as these molecules function at multiple points in development. For example, the BMP2-null mouse suffers from multiple defects and nonspecific cardiac malformation (Zhang and Bradley, 1996) , and BMP4 (Ϫ/Ϫ) embryos do not undergo gastrulation (Winnier et al., 1995) . Other traditional methods of misexpressing molecules such as RNA/ DNA injection in Xenopus and zebrafish have the disadvantage of poor tissue and time specificity of misexpression. This is particularly important when studying BMP signalling in the control of heart morphogenesis, as BMPs have been implicated in the initial induction of the heart primordium (Schultheiss et al., 1996; Lough et al., 1996; Shi et al., 2000) and determination of the left-right axis (Ramsdell and Yost, 1999) . Hence in order to distinguish direct effects of BMP misexpression on heart looping from indirect effects, it is necessary to be able to control the time and place of misexpression. Transgenic technology in Xenopus provides an ideal system to investigate these issues (Kroll and Amaya, 1996) . Transgenes are expressed in a time-and tissue-specific manner under the control of tissue-specific promoters, thus the role of a molecule at a single stage in heart development can be examined in the context of a normally developing embryo. Xenopus is well suited to these experiments, as the embryos develop externally, so the morphological changes in early heart development can be studied in real time. Additionally the embryos are not dependent on circulation for oxygen transportation at this stage, so otherwise fatal heart effects can be studied.
Here we show that BMP4 expression is predominantly localised to the left side of the developing heart tube in Xenopus, as it is in zebrafish. This expression is sensitive to perturbations in Xnr1 signalling. Using the transgenic system we found that expressing BMP4 throughout the heart tube randomises heart situs. Additionally, we show that inhibition of BMP signalling prevents the looping process, resulting in persistence of the linear heart tube. This tubular heart phenotype occurs in the context of an intact left-right axis. Finally inhibiting BMP signalling in the developing heart tube does not appear to affect chamber specification or anterior-posterior patterning of the heart.
MATERIALS AND METHODS

Generation of Plasmid Constructs
The cardiac actin promoter/GFP construct XCarGFP3 was generated by replacing the CMV promoter in CSGFP3 (Bronchain et al., 1999) with a 0.8-kb HindIII/partial XbaI fragment from pCarGFP containing the cardiac actin promoter (Kroll and Amaya, 1996) . XCarGFP3 contains a modified version of GFP (ZernickaGoetz et al., 1996) . Similarly, XCarNoggin, XCarTB4R, and XCarBMP4 were generated by cloning the respective cDNAs behind the cardiac actin promoter (Smith and Harland, 1992; Suzuki et al., 1997; Dale et al., 1985) . All XMLC2 promoter fusion constructs contained 3 kb of the Xenopus XMLC2␣ gene promoter (including the transcription start site) cloned in pBluescript II KS and separated by a polylinker from the SV40 late polyadenylation signal region (T.J.M., unpublished). The entire coding region of mGFP3 (Zernicka-Goetz et al., 1996) , BMP4 (Dale et al., 1985) , and noggin (Smith et al., 1993) and the truncated BMP4 receptor (Suzuki et al., 1997) were cloned via HindIII linkers into this vector.
Generation of Transgenic Embryos
Generation of transgenic Xenopus laevis embryos was carried out as described in Kroll and Amaya (1996) with the following modifications: 0.15 g DNA was added to 5 l sperm nuclei (1 ϫ 10 6 nuclei) per transgenic reaction. Four microliters of high-speed interphase egg extract was used per reaction. SalI was used in the transgenic reactions using the XMLC2BMP4 construct and NotI was used in all other reactions. The mixture with egg extract and restriction enzyme was incubated for 15 min at room temperature before being transplanted into dejellied, unfertilised eggs with a continuous flow injector as described (Amaya and Kroll, 1999) .
Whole-Mount in Situ Hybridisation
Whole-mount in situ hybridisation was carried out following the protocol of Harland (1991) except that embryos were incubated in 5 g/ml proteinase K for 10 min at room temperature. Antisense riboprobes for BMP4, noggin, and the truncated BMP4 receptor were labelled with digoxigenin-UTP (Roche), and those for cardiac actin, eHAND, Xtbx5, and Xpitx2 were labelled with fluorescein-UTP (Roche).
Double in situ hybridisations were visualised using BCIP (Xphosphate/5-bromo-4-chloro-3-indolyl phosphate) (Roche) for digoxigenin-labelled probes and magenta phosphate (X-phosphate/ 5-bromo-6-chloro-3-indolyl phosphate) (Molecular Probes) for fluorescein-labelled probes.
DNA/RNA Injections
The dorsal right blastomere of four-cell stage embryos was injected with 50 pg Xnr1 or Xnr2 DNA in the PCSKA plasmid, mixed with ␤-gal RNA, as previously described (Sampath et al., 1997) . Embryos were cultured at 16°C, until stage 32-33, when they were fixed in MEMFA for 1 h and then stained in X-gal, as previously described (Bourguignon et al., 1998) .
Sectioning of Embryos
Following whole-mount in situ hybridisation, embryos were stored in MEMFA. Embryos were rinsed twice for 5 min in phosphate-buffered saline (PBS) and then soaked for 30 min in 4 ml of a 1% gelatin-25% albumin mixture in PBS. The embryos were then embedded in the gelatin-albumin mixture by adding 150 l 25% glutaraldehyde (Sigma). Embedded embryos were sectioned on a Leica VT1000S Vibratome.
RT-PCR on Single Embryonic Hearts
The hearts of stage 45 embryos were dissected using two 22-gauge hypodermic needles, and RNA was isolated using Trizol reagent, using the protocol recommended by the manufacturer (Gibco BRL). After the final ethanol precipitation step, the dried RNA pellet was redissolved in 5 l RNase-free water, and DNA was synthesised using AMV reverse transcriptase (Roche). One microliter of this DNA solution was used as the substrate for PCR using histone H4 primers for control (5ЈCCGGATAACATTCAGGGTATCACT3Ј, 5ЈATC-CATGGCGGTAACTGTCTTCCT3Ј) and BMP4 transgene-specific primers (5Ј primer 500 bp 5Ј of the transcriptional stop codon of BMP4, 5ЈCTGGTCGCAGATGAGACCA3Ј, and the reverse-strand primer encoding 20 bases of the SV40 polyadenylation sequence, 5ЈTCTAGTTGTGGTTTGTCCA3Ј), yielding a 500-bp fragment (expected size) after 29 cycles of PCR.
RESULTS
BMP4 Is Asymmetrically Expressed in the X. laevis Heart Tube
Xenopus BMP4 has a complex and dynamic expression pattern (Fainsod et al., 1994; Hemmati-Brivanlou and Thomsen, 1995) . During the gastrula stages BMP4 is predominantly expressed in ventrolateral mesoderm and prospective nonneural ectoderm. During tailbud stages, BMP4 has a more complex expression pattern, including expression in the anterior mesendoderm, the dorsal ciliary margin of the eye, the otic vesicle, and the developing heart (Fainsod et al., 1994; HemmatiBrivanlou and Thomsen, 1995; Papalopulu and Kintner, 1996) . Since BMP4 is strongly expressed within the heart during the initial stages of heart morphogenesis and differentiation, we were interested in determining the role of BMP4 signalling during these critical stages of heart development. As a first step toward this goal, we examined in detail the expression profile of BMP4 in the developing heart. We found that BMP4 was initially expressed symmetrically throughout the developing heart area prior to tube formation at stage 30 (Figs. 1A-1D). At stage 32, when the heart tube has begun to roll up at the posterior end, asymmetric expression of BMP4 first becomes apparent (Figs. 1E-1H, 1N, and 1O). The asymmetric, left-sided, expression of BMP4 was apparent at the caudal end of the heart tube. The asymmetry persisted until stage 34, when dextral heart looping begins. For a detailed description of the morphological changes in the heart at these stages, refer to Mohun et al. (2000) . After completion of heart looping at stage 35, BMP4 expression was no longer asymmetric along the left-right axis (Figs. 1I-1L). Instead, BMP4 was expressed predominantly in the dorsal area of the presumptive atrium and ventricle. It is unclear whether this change of expression is due to the persistence of BMP4 expression in cells originally on the left side or due to a dynamic change of expression of BMP4 in the heart. Distinction between these two possibilities will require definitive fate mapping of the heart at these stages. In summary, BMP4 expression along the left-right axis is very dynamic, being apparent for a relatively short period of time, only from the linear heart tube stage until the initiation of heart looping. Similar results have also been described in zebrafish (Chen et al., 1997) . 
Xnr1 Expression Alters the Asymmetric Expression of BMP4 in the Heart Tube
It was previously reported that Xnr1 randomises heart situs when injected into the dorsal right blastomere at the four-cell stage (Sampath et al., 1997) . In contrast similar misexpression of Xnr2 had no effect on heart situs (Sampath et al., 1997) . In order to determine whether Xnr1 could affect the asymmetric expression of BMP4 in the linear heart tube, we injected CSKA-Xnr1 plasmids mixed with RNA encoding the lineage tracer ␤-galactosidase (␤-gal) into the dorsal right blastomere at the four-cell stage. After culturing to stage 33 and staining with X-gal, embryos exhibiting predominantly right-sided X-gal staining were separated and analysed by whole-mount in situ hybridisation to BMP4. Six embryos with right-sided X-gal staining were sectioned, and all showed a switch in BMP4 expression toward the right side of the posterior heart tube ( Fig.  2A) . No evidence of bilateral BMP4 expression was seen, thus the ectopic Xnr1 injection had switched BMP4 laterality. In contrast, BMP4 expression was not affected in embryos injected with Xnr2 (Fig. 2B) . Thus the asymmetric expression of BMP4 is sensitive to molecules that determine the left-right axis of the embryo.
Heart-Specific Expression in X. laevis Transgenic Embryos
In order to investigate the role of asymmetric BMP4 signalling in the control of heart looping, we have generated transgenic frog embryos that either up-regulate or downregulate BMP4 signalling within the linear heart tube. This approach relies on using a suitable promoter to drive transgene expression. Ideally, a promoter for use in this study should drive transgene expression symmetrically in the heart tube, at the time when BMP4 expression is asymmetric. In addition BMP4 transgene expression should be limited, as much as possible, to the heart, so that its role in heart looping can be studied in isolation from other roles that BMP4 may have in early embryos, such as in the patterning of the mesoderm (Dale et al., 1985; Fainsod et al., 1994; Dosch et al., 1997) , induction of the heart primordium (Schultheiss et al., 1996; Schlange et al., 2000; Shi et al., 2000) , and generation of the left-right axis (Ramsdell and Yost, 1999; Branford et al., 2000) .
We tested two promoters fused to GFP for expression in the developing heart of transgenic embryos: the Xenopus light chain 2 (XMLC2) promoter, which is expressed in the heart from the point of formation of the heart trough around stage 30 (B. Cooper, B. Latinkic, D. B. Sparrow, and T.J.M., unpublished results), and the cardiac actin promoter, which is expressed in the somites from stage 13 and in the heart from stage 30 (Mohun et al., 1986; Kroll and Amaya, 1996 ; B. Cooper, B. Latinkic, D. B. Sparrow, and T.J.M., unpublished results). Both promoters drive GFP expression in the precardiac tissue starting at stage 30, and transgene RNA was detectable equally on both sides of the linear heart tube between stages 32 and 34 (Figs. 3A, 3B , 3D, and 3E), when endogenous BMP4 expression is asymmetric. These promoter-GFP constructs can also be used to gain a realtime view of heart development in living embryos (Figs. 3C,  3F , and 3G).
Bilateral Overexpression of BMP4 in the Embryonic Heart Tube Randomises the Direction of Cardiac Looping
Transgenic embryos expressing BMP4 from the cardiac actin promoter displayed widespread disruptions in embryonic development, presumably as a consequence of the wider and earlier expression of BMP4 (Figs. 4I and 4J ). In contrast embryos expressing BMP4 from the XMCL2 promoter were normal in their development along the anteroposterior and dorsoventral axes (Figs. 4G and 4H ). Therefore we limited our BMP4 misexpression studies to transgenic embryos generated with the XMLC2BMP4 construct. At the same time, the embryos were also made transgenic for GFP under the cardiac actin promoter to mark the heart for visual scoring. We have found that when two transgene constructs were linearised with the same restriction enzyme and used in the same transgenesis reaction, their rate of co-integration in transgenic embryos was above 90% (K. Hartley, S. Nutt, O. Bronchain, and E.A., unpublished data). Stage 45 embryos were then examined for cardiac situs (Figs. 4A and 4B ). In embryos expressing both GFP and BMP4, the rate of dextrocardia (right-sided ventricle) was 30%, while embryos expressing GFP alone showed dextrocardia in only 8% of embryos (Table 1 ). The rate of 8% in the GFP control embryos was similar to the rate of 5% dextrocardia we measured in embryos derived from a wild- type mating, and a published rate of spontaneous dextrocardia (Lohr et al., 1996) .
To confirm transgene expression in embryos displaying levocardia, hearts were removed from 10 BMP4/GFP double-transgenic embryos exhibiting levocardia (normal, left-sided ventricle) and 6 siblings embryos exhibiting dextrocardia. RT-PCR was carried out, with BMP4 transgenespecific primers (i.e., one primer is specific to BMP4, while the other is specific to the SV40 polyadenylation sequence present in the transgene). We found that the BMP4 transgene was expressed in hearts displaying looping in either direction, suggesting that looping and eventual situs had been randomised rather than reversed (Fig. 4D) .
To show that the randomisation of situs was not due to disruption of the midline and thus a generalised left-right asymmetry defect (Danos and Yost, 1995; Bisgrove et al., 1999) , embryos transgenic for BMP4 were sectioned transversely. There was no evidence of disruption of the notochord (a measure of integrity of the embryonic midline) (Wasiak and Lohnes, 1999) (Fig. 4C) . In addition, we tested whether the left-right axis in these embryos had been generally disrupted by assaying for the expression of Xpitx2, which is normally left sided at the tailbud stages. We found that Xpitx2 expression remained left sided in the BMP4 transgenic embryos (Figs. 4E-4H ). Thus overexpression of BMP4 in the heart randomised heart situs without globally affecting the left-right axis. In contrast, embryos expressing BMP4 in the somites and heart showed disrupted Xpitx2 expression (Figs. 4I and 4J), suggesting that precocious BMP4 expression affects the left-right axis of the embryo.
Thus, asymmetric BMP4 expression appears to be a signal that controls the direction of heart looping during the time of heart looping morphogenesis. This role for BMP signalling is distinct from its participation in the generation of the left-right axis (Ramsdell and Yost, 1999; Branford et al., 2000) or its role in heart specification (Schultheiss et al., 1996; Schlange et al., 2000) . Misexpression of BMP4 on the right side of the embryo has been previously shown to produce inversion of cardiac situs in zebrafish (Schilling et al., 1999) , but in those experiments it was not possible to misexpress BMP4 specifically within the developing heart tube during the looping process.
Inhibition of BMP Signalling in the Embryonic Heart Tube Prevents Heart Looping
Having shown that asymmetric BMP4 expression is necessary for correct heart looping direction, we then tested the effect of inhibiting BMP4 signalling in the developing heart tube. Transgenic embryos were generated expressing noggin or the truncated BMP4 receptor throughout the heart field under the control of the cardiac actin or the XMCL promoter. noggin is a secreted molecule that binds BMP ligands, thus preventing them from binding to their cognate receptors (Smith et al., 1993; Zimmerman et al., 1996) . The truncated BMP4 receptor (tBR) inhibits BMP signalling (Suzuki et al., 1997) . By driving these transgenes throughout the heart tube, BMP signalling can be inhibited bilaterally. Since expressing noggin or tBR from the cardiac actin promoter did not adversely affect embryonic development (Fig. 5A) , we used this promoter as well as the XMLC2 promoter to inhibit BMP signalling in the linear heart tube. Transgenic embryos were fixed at stage 38 -39 and stained for expression of both the transgene and the endogenous cardiac actin mRNA by double in situ hybridisation (Figs.  5C and 5D ). The endogenous cardiac actin stain permitted easy visualisation of the heart anatomy in embryos that were not transgenic. Since not all embryos generated by the transgenic technique carry the transgene, due to the random nature of the integration events, nontransgenic siblings act as internal controls. As shown in Table 2 , 66% of the embryos expressing noggin and 71% of tBR expressing embryos did not undergo cardiac looping. These heart tubes beat in a peristaltic manner in a caudorostral direction, suggesting that the ventricular and atrial precursors have been specified correctly. This is also consistent with the development of normal electrophysiological function in which the ventricle is paced by the atria, except that in the unlooped heart the atria differentiates posterior to the ventricle (Fishman and Olson, 1997) . If the unlooped heart tube were allowed to develop further, gross morphologic regionalisation could be seen. Figure 5B shows an embryo transgenic for both CARGFP and CARNoggin. The increase in GFP fluorescence in the area of the future ventricle is due to increased myocardial thickness compared with surrounding portions of the tube, consistent with ventricular chamber morphology and suggesting that chamber specification is unaffected by inhibiting the looping process. Additionally, the sinus venosus (future atrium) can be seen to have moved dorsally, which occurs in the normally looped heart. Thus this dorsal movement of the future atrium does not appear to depend on heart looping. Next we determined the effect of inhibiting BMP signalling on Tbx5, a marker of the presumptive atrial region (Horb and Thomsen, 1999) (Figs. 5E and 5F ). While transgenic embryos expressing noggin in the heart fail to loop, Tbx5 expression remains in the atrial pole of the linear heart tube (Fig. 5F ). These results suggest that regionalisation of the Xenopus heart tube continues even when the looping process is inhibited. Thus, these two processes appear to be molecularly independent.
DISCUSSION
The aim of this work has been to investigate the role of BMP4 during heart looping morphogenesis. Left-sided BMP4 expression in the developing heart has previously been documented in zebrafish (Chen et al., 1997; Schilling et al., 1999) . Whole-mount RNA in situ hybridisation to endogenous BMP4 RNA in Xenopus embryos between stages 30 and 35 revealed that BMP4 RNA is similarly expressed asymmetrically in the linear heart tube and that this asymmetry is maintained through the early stages of the looping process. We also show that right-sided misexpression of Xnr1, which randomises heart situs (Sampath et al., 1997) , switches the asymmetric BMP4 expression to the right side of the heart tube. These findings provide a molecular mechanism for the mode of activity of Xnr1 on the developing heart and link asymmetric BMP4 expression in the heart tube to the left-right axis. The finding that up-regulation of Xnr1 switches unilateral expression of BMP4 rather than up-regulating expression bilaterally suggests that there may be an additional regulatory step(s) in the pathway between these two factors, and the unitary "left-right decision" is made before unilateral expression of BMP4 is established.
Experiments in zebrafish have suggested that BMP4 may play a role linking the left-right axis to directional heart looping (Chen et al., 1997; Schilling et al., 1999) . In an attempt to test whether BMP signalling has a direct role in controlling heart looping morphogenesis, we generated transgenic embryos that either up-regulate or downregulate BMP signalling specifically in the heart during the looping process. While attempts to manipulate the BMP signalling pathway in zebrafish have resulted in randomisation of the direction of heart (Chen et al., 1997; Schilling et al., 1999) , it has been difficult to ascertain whether the effects seen have been a direct or indirect effect on the looping process. The reason for this is that, in those experiments, RNAs encoding a dominant negative BMP4 receptor construct or full-length BMP4 were injected into one-to two-cell stage embryos and the effect on heart looping was tested around 30 h later. Therefore disruption in the looping process could have been a direct effect or an Note. Transgenic embryos were generated with the CARGFP construct either alone or in combination with the XMCL2BMP4 construct. At stage 40, the resulting healthy embryos were examined for prevalence of left-sided heart looping (levocardia) or right-sided heart looping (dextrocardia). In addition the prevalence of left-sided versus right-sided heart looping was determined in embryos generated from a natural mating. (n) Number of embryos examined.
FIG. 5.
Expression of noggin throughout the heart tube prevents dextral cardiac looping, but does not affect chamber specification. indirect effect resulting from perturbations in the left-right axis. For example, BMP4 signalling has been proposed to impart right-sided identity in Xenopus at a point long before formation of the cardiac tube (Hyatt and Yost, 1998; Ramsdell and Yost, 1999) . In addition misexpressing BMP4 during early development is known to ventralise embryos, destroying the dorsal midline, which has been shown to be important for the normal establishment of the left-right axis (Bisgrove et al., 1999) .
We have overcome the difficulties in studying a multifunctioning molecule, such as BMP4, by using a heartspecific promoter to drive BMP4 expression in a temporospatially controlled manner in transgenic embryos. Using this approach we have shown that bilateral expression of BMP4 increases the incidence of dextrocardia towards randomisation (30% versus 5-8% in control embryos). However, we did not see evidence of complete randomisation of heart situs (i.e., 50% dextrocardia). This may have been due to the influence of unidentified signalling molecules, which can influence heart situs in combination with BMP4. Alternatively it may have been due to the nature of the technique used to generate the transgenic embryos. The REMI technique results in a variable number of integrations in each embryo (Kroll and Amaya, 1996) , resulting in variable dosage levels of transgene expression. It is therefore possible that only embryos expressing larger amounts of BMP4 were able completely to overcome the influence of endogenous left-sided BMP4 expression.
The XMLC2 promoter, used for these studies, commences transcriptional activity during the formation of the heart tube, when the left-right axis is considered to be specified . Thus randomisation of cardiac situs by forcing bilateral expression of BMP4 in the heart tube is due to the action of BMP4 on the heart tube rather than a more global effect on the left-right axis or midline formation. Importantly, Xpitx2, a transcription factor whose normal left-sided expression has been shown to be dependent on Xnr1 signalling (Campione et al., 1999) , is unaffected in XMLC2BMP4 transgenic embryos. Hence BMP4 plays a direct role in imparting laterality to the heart tube, as opposed to having indirect effects on the left-right axis of the embryo. The importance of the spatiotemporal control of transgene expression is shown by transgenic Xenopus embryos expressing BMP4 driven from the cardiac actin promoter, which is active in the somites well before it is active in the heart. These embryos suffer multiple developmental abnormalities including disruption to the left axis, whereas those with the XMLC2BMP4 construct develop normally. Thus the effects we have observed are due to the direct action of BMP4 on the heart. Both noggin and the truncated BMP receptor inhibit cardiac looping when expressed throughout the heart tube. Given that other BMP ligands are expressed in the heart tube during these stages (Hemmati-Brivanlou and Thomsen, 1995; Clement et al., 1995; Wang et al., 1997) and that noggin and the truncated BMP receptor are not ligand specific, the effect of noggin and the truncated BMP receptor on heart-looping morphogenesis may be due to a combined inhibition of all these BMP ligands. This may also explain the possible discrepancy that global misexpression of BMP4 gives randomisation while global inhibition of BMP signalling results in failure to undergo looping morphogenesis. Indeed it will be important in the future to investigate whether BMP4 alone is involved in this process or whether it functions in cooperation with other BMP ligands.
A number of previous studies have generated unlooped heart tubes by a variety of methods. Mouse null mutants of Nkx2-5 (Lyons et al., 1995) , Hand2 (Srivastava et al., 1997) , and Mef2c have produced hypoplastic, unlooped heart tubes. In this study, however, the unlooped heart phenotype is distinct from those mentioned above, as peristaltic beating and some evidence of regionalisation are observed, as assayed by Tbx5 expression. Another perturbation in the mouse which leads to a similar phenotype is the expression of a constitutively active ALK5 mutation specifically in the heart (Charng et al., 1998) . Whether this perturbation is molecularly distinct or in the same pathway as the one we describe will require further evaluation. Eventually the embryos lacking BMP signalling in the heart become oedematous, suggesting that cardiac function is Note. Transgenic embryos were generated with the following constructs: CARGFP, XCARNOG, and XCARtB (GFP, noggin, and the dominant negative BMP4 receptor, respectively, under the control of the cardiac actin promoter) and XMCLNOG and XMLCtBR (noggin and the dominant negative BMP4 receptor, respectively, under the control of the myosin light chain 2 promoter). Stage 37-38 embryos were separated into (ϩ) and (Ϫ) groups according to whether transgene was detectable by in situ hybridisation and then scored for whether the heart had undergone looping. "⌬ Embryos" signifies embryos that exhibited injection injuries or nonspecific abnormalities such as spina bifida. (n) Number of embryos examined.
inadequate. Our current model is that Xnr1 expression in the lateral plate mesoderm induces asymmetric, left-sided BMP4 expression in the heart tube, which then drives the cellular changes underlying heart looping. This process is apparently independent of events leading to the specification of the anteroposterior axis of the heart tube as well as those leading to chamber specification. However, in the absence of definitive chamber-specific markers in X. laevis, the exact nature of the link between the control of heart looping and chamber specification and morphogenesis will require further evaluation.
One question that remains is what controls the asymmetric expression of BMP4 in the linear heart? While we show that asymmetric BMP4 expression is sensitive to Xnr1 misexpression, we do not believe that Xnr1 directly regulates BMP4 in the heart tube. This is because endogenous Xnr1 expression ceases in the left lateral plate mesoderm well before the heart tube stage (Lustig et al., 1996) . Therefore, it seems more likely that induction of asymmetric BMP4 in the heart tube by Xnr1 occurs via intermediate signals, which are as yet undefined. A candidate for such a signal is Xlefty, which has been shown to be expressed asymmetrically in the heart field at stage 28 -30 (Branford et al., 2000) . However we have found that this asymmetric expression is not maintained at the heart tube stages (data not shown). Another candidate molecule that may directly regulate the asymmetric expression of BMP4 in the linear heart tube is the transcription factor Xpitx2, which has been shown to be asymmetrically expressed in the heart (Campione et al., 1999) . However, we have found that, although Xpitx2 expression partially overlaps with that of BMP4, the expression is not completely coincident (data not shown). Therefore, Xpitx2 is unlikely to directly regulate BMP4. Future work will be required to ascertain which signalling molecule and/or transcription factor directly regulates the asymmetric expression of BMP4 in the linear heart tube.
Interestingly, transgenic embryos expressing noggin or tBR from the cardiac actin promoter exhibit grossly normal development, whereas transgenic embryos expressing BMP4 from the same promoter develop abnormally. This suggests that strong early somitic expression of BMP4 is incompatible with normal development. This is consistent with the findings of Larrain et al. (2000) , who have shown that the N-terminus of Xenopus procollagen type IIA, which is highly expressed in the somites and notochord, contains a cysteine-rich chordin-like domain which has anti-BMP activity (Larrain et al., 2000) . Thus the somites (and notochord) normally express high levels of an anti-BMP molecule; therefore, expressing further antagonists of BMP has little effect on development. However, overexpressing high levels of BMP4 may counteract the endogenous anti-BMP molecules in the somites, leading to abnormal development.
While this study implicates BMP4 as the signalling link between the left-right axis and heart morphogenesis, the cellular basis of the subsequent asymmetric morphological changes resulting in heart looping remains to be determined. In theory, differential cell proliferation, apoptosis, or changes in cell adhesion/shape on one side of the unlooped heart tube could produce looping. Recently, apoptosis has been studied in the developing heart and has been found to be BMP4 dependent (Zhao and Rivkees, 2000) . This study, however, was done at stages well after looping has occurred. Whether BMP-4 signalling has an effect on cell proliferation, apoptosis, or cell adhesion/shape during heart looping morphogenesis remains to be determined. The Xenopus transgenic system should provide a good experimental model to further investigate the molecular and cellular basis of heart looping morphogenesis.
